Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
This study is currently recruiting participants.
Study NCT00453375   Information provided by Bayhill Therapeutics
First Received: March 26, 2007   Last Updated: June 10, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Hypoglycemia
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
BHT-3021
BHT-Placebo
Additional drug interventions recognized in this trial
Butylated Hydroxytoluene
More general drug interventions related to this trial
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
Bayhill Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services